Francesca Gatta*, Christine Bojanic, Safia Elbagir Abdulla, Claire Edwards
Gatta et al. J Clin Transl Res 2022; 8(6):17
Published online: November 24, 2022
Abstract
Background and aim: The COVID-19 pandemic, the new ISCP curriculum and the EWTD significantly reduced surgical exposure for trainees. This study analysed the operative experience of Phase 1 trainees (CT1/ST1 vs CT2/ST2) against the ARCP criterion of 120 procedures yearly.
Methods: National survey research in October 2021. Study end-point was the completion of >4 weekly procedures, equivalent to 120 cases per year. Chi-Square test and multivariate regression analysis were performed.
Results: 205 participants from 5 Deaneries were included, 48.3% were CT1/ST1 and 51.7% were CT2/ST2. 54.5% of year-1 and 50% of year-2 trainees were 28-30 years old, 55.6% and 50.9% were male, and 39.4% and 38.7% were White British. 39.4% of CT1/ST1 and 22.6% of CT2/ST2 performed <4 weekly procedures (p=0.01), with no difference in the “Observed” (p=0.6) or “Assisted” (p=0.3) number of cases. CT2/ST2 recorded more “ST-S” (p 0.04), “S-TU” (p=0.03) and “Performed” (p=0.02) operations. For CT1/ST1, older age (HR 2.4, 95% CI [1.1; 5.3], p 0.02) and southern deaneries (HR 1.7, 95% CI [1.2; 2.4], p 0.004) were independent factor for <4 weekly procedures. For CT2/ST2, northern regions were associated with more favourable training (HR 1.4, 95% CI [1.1;1.7], p=0.01).
Conclusion: Over one third of Phase 1 trainees do not meet the ARCP requirement of >120 procedures annually. Age and region of training are independent factors in the number of logbook cases.
Relevance for patients: This research focuses on training opportunities for junior surgical residents across the United Kingdom. The degree and type of exposure to the operating theatre has a significant impact on the development of surgical competencies. These are undoubtedly related to patient outcomes, as the quality of care delivered to patients and relatives greatly relies on the training background of future consultant surgeons.
DOI: http://dx.doi.org/10.18053/jctres.08.202206.017
Author affiliation
1. Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK
2. General Surgery, Addenbrooke’s Hospital, Cambridge, UK
3. Orthopaedic Surgery, Norfolk and Norwich University Hospital, Norwich, UK
*Corresponding author
Francesca Gatta
Cardiothoracic Surgery, Liverpool Heart and Chest Hospital, UK
Email: Francesca.gatta@lhch.nhs.uk
Handling editor:
Michal Heger
Department of Pharmaceutics, Utrecht University, the Netherlands
Department of Pharmaceutics, Jiaxing University Medical College, Zhejiang, China
Downloads
Full text PDF
Review process file (158.5 KB)
Appendix 1 (143.0 KB)
